Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2008 June;33(2) > Minerva Endocrinologica 2008 June;33(2):95-104

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118


eTOC

 

REVIEWS  NUCLEAR MEDICINE AND ENDOCRINOLOGY I


Minerva Endocrinologica 2008 June;33(2):95-104

language: English

Nuclear medicine techniques for radio-guided surgery of hyperparathyroidism

Ugur Ö. 1, Bozkurt M. F. 1, Rubello D. 2

1 Department of Nuclear Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey
2 Nuclear Medicine Service-PET Unit, S. Maria della Misericordia Hospital, Istituto Oncologico Veneto (IOV)-IRCCS, Rovigo, Italy


PDF  


In recent years there has been a prominent change in surgical trends from extensive approaches to minimally invasive techniques in hyperparathyroidism. In contrast to classical bilateral exploration methods, minimally invasive parathyroidectomy necessitates an adequate preoperative imaging modality, in order to focus exactly the lesion in interest. 99mTc-MIBI, as a highly sensitive and widely available radiopharmaceutical, provides high success rates in terms of preoperative parathyroid lesion localization. Besides preoperative imaging, minimally invasive parathyroidectomy also requires an intraoperative modality which can act as a guide to surgeon. Hand-held gamma probes are simply-operated lesion localization devices which serve as successful intraoperative guides to surgeon. 99mTc-MIBI based minimal invasive parathyroidectomy has replaced the traditional 4 gland exploration as the procedure of choice in many institutions with comparable cure rates.

top of page

Publication History

Cite this article as

Corresponding author e-mail